Issue of Equity

RNS Number : 7981S
First Derivatives PLC
13 March 2019
 

13 March 2019

 

First Derivatives plc

("FD" or the "Company")

 

Issue of Equity

 

FD (AIM: FDP.L, ESM: FDP.I) announces the allotment of 72,000 new ordinary shares of 0.5p each in the Company (the "Ordinary Shares") pursuant to the exercise of share options by certain employees.

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 20 March 2019. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following these allotments, the total issued share capital of the Company will increase to 26,234,258 ordinary shares.

 

Enquiries

For further information please contact:

 

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 5970

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

 

About FD

FD is a global technology provider with 20 years of experience working with some of the world's largest finance, technology, retail, pharma, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 14 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,600 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOECKNDPABKDKND
UK 100

Latest directors dealings